SIRO Clinpharm named Indian CRO of the Year 2012
The award was received by Gopakumar Menon, CEO, SIRO Clinpharm on behalf of the employees. "I am proud to receive this award as an ambassador of exceptional professionals across three continents, whose daily pursuit of excellence has resulted in SIRO Clinpharm receiving this award for two consecutive years," he said.
Ajaykumar Sharma, associate director of pharma and biotech, South Asia and Middle East, Frost & Sullivan, added, "With all the regulatory challenges which had taken off the sheen from the Indian CRO industry in the last few years, it is amazing to see a company repeating this feat for the second year in a row.”
The award is a testimony to SIRO Clinpharm's commitment in supporting its stakeholders through ethical, transparent and best-in-class services.
"As the Indian markets open to the western world, there are a number of challenges we face not just as a company but as an industry,” said Vatsal Shah, head of medical writing and pharmacovigilance, SIRO. “However, we have been able to convert these challenges into opportunities by ensuring process excellence, improving service delivery and focusing on training and development of our resources—thus, delivering a spectrum of services that is unique to the industry.”